Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4918
BRTX
BioRestorative Therapies, Inc. - Common Stock
0.20 USD0.00%-13.04%-4.76%-89.25%5.10 M USD
4920
MLEC
Moolec Science SA - Ordinary Shares
6.80 USD0.00%-5.29%-2.02%+389.21%4.94 M USD
4935
ADXN
Addex Therapeutics Ltd - American Depositary Shares
3.81 USD-2.81%-2.31%-33.74%-52.90%4.69 M USD
4939
EVGN
Evogene Ltd. - Ordinary Shares
0.53 USD-1.85%-1.85%+8.16%-57.60%4.62 M USD

Frequently asked questions about Liminatus Pharma, Inc. Class A Common Stock

What is the Liminatus Pharma, Inc. Class A Common Stock stock price today?

The current price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is 3.60. Over the past 24 hours, the stock has changed by -6.74%. Follow the LIMN chart for real-time price dynamics.

What is the stock ticker of Liminatus Pharma, Inc. Class A Common Stock?

Liminatus Pharma, Inc. Class A Common Stock trades under the ticker LIMN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Liminatus Pharma, Inc. Class A Common Stock stock going up?

LIMN has changed by -21.91% over the last week, +3172.73% over the last month, and +22.03% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Liminatus Pharma, Inc. Class A Common Stock?

Liminatus Pharma, Inc. Class A Common Stock currently has a market capitalization of 4.84 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Liminatus Pharma, Inc. Class A Common Stock earnings last quarter?

Last quarter, Liminatus Pharma, Inc. Class A Common Stock reported earnings of -1.5 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Liminatus Pharma, Inc. Class A Common Stock net income for the last quarter?

Liminatus Pharma, Inc. Class A Common Stock reported net income of -1.41 M for the last quarter. The previous quarter showed -1.12 M, which means net income changed by -25.23%.

How many employees does Liminatus Pharma, Inc. Class A Common Stock have?

As of the latest available data, Liminatus Pharma, Inc. Class A Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Liminatus Pharma, Inc. Class A Common Stock stock?

You can buy Liminatus Pharma, Inc. Class A Common Stock (LIMN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Liminatus Pharma, Inc. Class A Common Stock stock?

Investing in Liminatus Pharma, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LIMN chart and related analysis on metatrader.com as part of your research.